Peptides against 12-LOX, such as the one formed by tyrosine, tryptophan, cysteine and serine residues (YWCS), have also been developed and suggested for breast cancer treatment, and specific 12-LOX inhibitors, such as baicalein, due to their tumor-suppressive and anti-angiogenesis effects [192,193]. This evidence concerns the gene ALOX15 and breast cancer.